Oncotarget

Research Papers:

Long non-coding RNA HULC as a novel serum biomarker for diagnosis and prognosis prediction of gastric cancer

Chunjing Jin _, Wei Shi, Feng Wang, Xianjuan Shen, Jing Qi, Hui Cong, Jie Yuan, Linying Shi, Bingying Zhu, Xi Luo, Yan Zhang and Shaoqing Ju

PDF  |  HTML  |  Supplementary Files  |  How to cite

Oncotarget. 2016; 7:51763-51772. https://doi.org/10.18632/oncotarget.10107

Metrics: PDF 3085 views  |   HTML 3016 views  |   ?  


Abstract

Chunjing Jin1,*, Wei Shi2,*, Feng Wang3,*, Xianjuan Shen2, Jing Qi2, Hui Cong3, Jie Yuan1, Linying Shi1, Bingying Zhu1, Xi Luo1, Yan Zhang1, Shaoqing Ju2,3

1Medical School of Medicine, Nantong University, Nantong 226000, Jiangsu Province, China

2Surgical Comprehensive Laboratory, Affiliated Hospital of Nantong University, Nantong 226000, Jiangsu Province, China

3Laboratory Medicine Center, Affiliated Hospital of Nantong University, Nantong 226000, Jiangsu Province, China

*These authors have contributed equally to the work

Correspondence to:

Shaoqing Ju, email: [email protected]

Keywords: gastric cancer, long non-coding RNA, biomarker, HULC

Received: January 25, 2016    Accepted: May 02, 2016    Published: June 16, 2016

ABSTRACT

Long non-coding RNAs (lncRNAs) have recently emerged as vital players in tumor biology with potential value in cancer diagnosis, prognosis, and therapeutics. The lncRNA HULC (highly up-regulated in liver cancer) is increased in many malignancies, yet its serum expression profile and clinical value in gastric cancer (GC) patients remain unclear. Quantitative real-time polymerase chain reaction (RT-qPCR) for large-scale analysis of the serum expression of HULC in GC patients reliably detected circulating HULC and revealed that it is upregulated in GC patients. A high serum HULC level correlated with tumor size, lymph node metastasis, distant metastasis, tumor-node-metastasis stage, and H. pylori infection. The area under the ROC curve for HULC was up to 0.888, which was higher than that for CEA (0.694) and CA72-4 (0.514). Follow-up detection and Kaplan-Meier curve analysis revealed HULC is a good predictor of GC prognosis. Our present study indicates that circulating HULC may represent a novel serum tumor marker for early diagnosis and monitoring progression and prognosis of GC.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 10107